uric acid has been researched along with Grippe in 3 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Excerpt | Relevance | Reference |
---|---|---|
"The clinical signs and symptoms of influenza and quantitative viral shedding were the same in ribavirin- and placebo-treated groups." | 2.65 | Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection. ( Charette, RP; Cooney, MK; Fox, JP; Hall, CE; Smith, CB, 1980) |
"In addition to influenza viruses, FVP demonstrates a broad-spectrum activity against many RNA viruses including Ebola, Lassa, rabies, and severe fever with thrombocytopenia [2]." | 1.62 | Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients. ( Başaran, NÇ; İnkaya, AÇ; Kara, E; Şahin, TK; Ünal, S; Uyaroğlu, OA; Uzun, Ö, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
İnkaya, AÇ | 1 |
Kara, E | 1 |
Başaran, NÇ | 1 |
Şahin, TK | 1 |
Uyaroğlu, OA | 1 |
Uzun, Ö | 1 |
Ünal, S | 1 |
Ciapetti, M | 1 |
Mancinelli, P | 1 |
Cecchi, A | 1 |
Borrelli, E | 1 |
Bocci, V | 1 |
Peris, A | 1 |
Smith, CB | 1 |
Charette, RP | 1 |
Fox, JP | 1 |
Cooney, MK | 1 |
Hall, CE | 1 |
1 trial available for uric acid and Grippe
Article | Year |
---|---|
Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection.
Topics: Administration, Oral; Bilirubin; Complement Fixation Tests; Double-Blind Method; Erythrocyte Count; | 1980 |
2 other studies available for uric acid and Grippe
Article | Year |
---|---|
Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients.
Topics: Biomarkers; COVID-19 Drug Treatment; Humans; Hypoxanthine Phosphoribosyltransferase; Influenza, Huma | 2021 |
Reduction of non-enzymatic antioxidants in plasma during ECMO-treatment in ARDS by influence A H1N1.
Topics: Antioxidants; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Vir | 2018 |